Effect of Lipid Composition on Topical Delivery of Cyclosporin-A from Nonionic Ldtosomal Formulations: An in Vitro Study with Hairless Mouse Skin

Journal of Liposome Research

Volumn 7, Issue 42038, 1997, Pages 261-271

  Waranuch, Neti ^a   Ramachandran, Chandrasekharan ^a   Weiner, Norman D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLOSPORIN A; GLYCEROL DERIVATIVE; LIPOSOME; POLYOXYETHYLENE STEARYL ETHER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG UPTAKE; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN PERMEABILITY; TISSUE DISTRIBUTION;

EID: 0030742707     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982109709035501     Document Type: Article

References (16)

1. Laburte C., Grossman R., Abi-Rached J., Abeywickrama K.H., Dubertret L. Efficacy and safety of oral cyclosporin A (Cy A; Sandimmun) for long term treatment of chronic severe plaque psoriasis. Br. J. Dermatol. 1994; 130: 366 – 375
2. Honeyman J.F., Sanchez L., Valdes P. Low-dose cyclosporine A improves severe disabling psoriasis in Latin America. Latin American Muticenter Study. Int. J. Dermatol. 1995; 34: 583 – 588
3. Gupta A.K., Ellis C.N., Cooper K.D., Nickoloff B.J., Ho V.C., Chan L.S., Hamilton T.A., Tellner D.C., Griffiths C.E., Voorhees J.J. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J. Am. Acad. Dermatol. 1990; 22: 242 – 250
4. Ho V.C., Griffiths C.E., Ellis C.N., Gupta A.K., McCuaig C.C., Nickoloff B.J., Cooper K.D., Hamilton T.A., Voorhees J.J. Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study. J. Am. Acad. Dermatol. 1992; 22: 94 – 100
5. Burns M.K., Ellis C.N., Eisen D., Duell E., Griffiths C.E., Annesley T.M., Hamilton T.A., Birnbaum J.E., Voorhees J.J. Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacy. Arch. Dermatol. 1992; 128: 786 – 790
6. Pei Y., Scholey J.W., Katz A., Schachter R., Murphy G.F., Cattran D. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine. Am. J. Kidney Dis. 1994; 23: 528 – 536
7. Brown A.L., Wilkinson R., Thomas T.H., Levell N., Munro C., Marks J., Goodship T.H. The effect of short-term low-dose cyclosporin on renal function and blood pressure in patients with psoriasis. Br. J. Dermatol. 1993; 128: 550 – 555
8. Messana J.M., Johnson K.J., Mihatsch M.J. Renal structure and function effects after low dose cyclosporine in psoriasis patients: a preliminary report. Clin. Nephrol. 1995; 43: 150 – 153
9. Zachariae H., Stee Olsen T. Efficacy of cyclosporin A (Cy A) in psoriasis: an overview of dose/response, indications, contraindications and side-effects. Clin. Nephrol. 1995; 43: 154 – 158
10. Young E.W., Ellis C.N., Messana J.M., Johnson K.J., Leichtman A.B., Mihatsch M.J., Hamilton T.A., Groisser D.S., Fradin M.S., Voorhees J.J. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int. 1994; 46: 1216 – 1222
11. Duncan J.I., Wakeel R.A., Winfield A.J., Ormerod A.D., Thomson A.W. Immunomodulation of psoriasis with a topical cyclosporin A formulation. Acta. Derm. Venereol. 1993; 73: 84 – 87
12. Choi H.K., Flynn G.L., Amidon G.L. Percutaneous absorption and dermal delivery of cyclosporin A. J. Pharm. Sci. 1995; 84: 581 – 583
13. Hermann R.C., Taylor R.S., Ellis C.N., Williams N.A., Weiner N.D., Flynn G.L., Annesley T.M., Voorhees J.J. Topical cyclosporin for psoriasis: in vitro skin penetration and clinical study. Skin Pharmacol. 1988; 1: 246 – 249
14. Dowton S.M., Hu Z., Ramachandran C., Wallach D.F.H., Weiner N. Influence of liposomal composition on topical delivery of encapsulated cyclosporin A. I. An in vitro study using hairless mouse skin. S.T.P. Pharma. Sci. 1993; 3: 404 – 407
15. Hu Z., Niemiec S.M., Ramachandran C., Wallach D.F.H., Weiner N. Topical delivery of cyclosporin A from non-ionic liposomal systems: An in vivo/in vitro correlation study using hairless mouse skin. S.T.P. Pharma. Sci. 1994; 4: 466 – 469
16. Hofland H.E., van der Geest R., Bodde H.E., Junginger H.E., Bouwstra J.A. Estradiol permeation from nonionic surfactant vesicles through human stratum comeum in vitro. Pharm. Res. 1994; 11: 659 – 664